- Home
- AGRO vs ETNB Comparison
AGRO vs ETNB Comparison
Compare AGRO & ETNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGRO
- ETNB
- Stock Information
- Founded
- AGRO 2002
- ETNB 2018
- Country
- AGRO Luxembourg
- ETNB United States
- Employees
- AGRO N/A
- ETNB N/A
- Industry
- AGRO Farming/Seeds/Milling
- ETNB Biotechnology: Pharmaceutical Preparations
- Sector
- AGRO Consumer Staples
- ETNB Health Care
- Exchange
- AGRO Nasdaq
- ETNB Nasdaq
- Market Cap
- AGRO 1.1B
- ETNB 1.0B
- IPO Year
- AGRO 2011
- ETNB 2019
- Fundamental
- Price
- AGRO $8.68
- ETNB $7.79
- Analyst Decision
- AGRO Hold
- ETNB Strong Buy
- Analyst Count
- AGRO 4
- ETNB 9
- Target Price
- AGRO $11.60
- ETNB $27.25
- AVG Volume (30 Days)
- AGRO 1.3M
- ETNB 1.5M
- Earning Date
- AGRO 05-19-2025
- ETNB 05-01-2025
- Dividend Yield
- AGRO 4.03%
- ETNB N/A
- EPS Growth
- AGRO N/A
- ETNB N/A
- EPS
- AGRO 0.90
- ETNB N/A
- Revenue
- AGRO $1,518,907,000.00
- ETNB N/A
- Revenue This Year
- AGRO $1.26
- ETNB N/A
- Revenue Next Year
- AGRO $0.78
- ETNB N/A
- P/E Ratio
- AGRO $9.61
- ETNB N/A
- Revenue Growth
- AGRO 16.94
- ETNB N/A
- 52 Week Low
- AGRO $8.72
- ETNB $4.16
- 52 Week High
- AGRO $12.08
- ETNB $11.84
- Technical
- Relative Strength Index (RSI)
- AGRO 29.02
- ETNB 54.56
- Support Level
- AGRO $8.45
- ETNB $6.55
- Resistance Level
- AGRO $11.79
- ETNB $8.92
- Average True Range (ATR)
- AGRO 0.40
- ETNB 0.57
- MACD
- AGRO -0.21
- ETNB 0.17
- Stochastic Oscillator
- AGRO 6.74
- ETNB 63.69
About AGRO Adecoagro S.A.
Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The company operates through three segments namely Farming, Sugar, Ethanol and Energy, and Land Transformation. The Farming segment consists of planting, harvesting, and sale of grains, oilseeds and fibers, rice, and production and sale of dairy products; the Sugar, Ethanol, and Energy segment consists of cultivating sugar cane which is processed in owned sugar mills, transformed into ethanol; and the Land Transformation segment comprises identification and acquisition of underdeveloped and undermanaged farmland.
About ETNB 89bio Inc.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).